Unsolved Chronic Wounds Increasing Rapidly In India…
Pharma Bio World|November 2018
Unsolved Chronic Wounds Increasing Rapidly In India…

+dalethyne, a path breaking molecule, only one of its kind in the world, invented after 18 years of untiring research since 2000 by K.S. Dharshan, the Founder and Chairman of Indonesia based Dermozone , is all set to revolutionize the wound care market in India. +dalethyne would be the key ingredient of the new Dermozone range of wound care products soon to be launched in India. Mr. K.S. Dharshan, CEO – Dermozone gives us more details in this brief interview with PharmaBio World.

What is the main constituent of +dalethyne?

+dalethyne is a clinically tested compound obtained from artificial segregation of naturally abundant fatty acids in virgin olive oil.

What are the targets of this pathbreaking molecule?

+dalethyne, a breakthrough in medicinal science, would be the key ingredient of the soon to be launched Dermozone range of wound care products that would be a new hope for unsolved chronic, acute, cancer radiotherapy and burn wounds, which are now increasing rapidly in India.

Is + dalethynea life - saving compound?

A) In many cases our wound care products (the key ingredient being +dalethyne) have been lifesaving and have also prevented near certain amputations of patients suffering from diabetic related wounds.

What is the USP of +dalethyne?

It has proven effect of anti-microbial, fungicidal and antiviral quality with deep skin-penetrable quality. Investigations have revealed that +dalethyne reduces in flammat ion and accelerates wound healing.

What is the patent grade value of this compound?

articleRead

You can read up to 3 premium stories before you subscribe to Magzter GOLD

Log in, if you are already a subscriber

GoldLogo

Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines

READ THE ENTIRE ISSUE

November 2018